Analyst Lyanne Harrison of Bank of America Securities reiterated a Buy rating on Resmed (RMD – Research Report), retaining the price target of ...
Ritholtz Wealth Management lessened its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 79.7% in the fourth ...
Aaron Wealth Advisors LLC lifted its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 25.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional ...
The stock's rise snapped a four-day losing streak.
Shares of ResMed Inc. RMD slumped 0.62% to $228.83 Tuesday, on what proved to be an all-around favorable trading session for ...
The investing pros at Firetrail forecast another strong year for ResMed shares in 2025. The post ResMed shares are up 42% in ...
Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.
Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...
Zacks.com on MSN18d
ResMed Gains 37.8% in a Year: What's Driving the Stock?RMD's shares gain on the back of robust mask and device sales growth. However, the unfavorable macroeconomic scenario is ...
The S&P 500 added 0.7% on Monday, Dec. 23, 2024, with tech stocks outperforming as the holiday-shortened week got underway.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback